Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
1.270
-0.030 (-2.31%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Akso Health Group Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
0.17176.2385.177.9218.43
Cash & Short-Term Investments
0.17176.2385.177.9218.43
Cash Growth
-99.90%106.91%974.82%-57.00%21.82%
Accounts Receivable
1.280.95-7.7-
Receivables
1.2812.9-9.2320
Inventory
0.20.190.191.697.8
Other Current Assets
187.896.8156.651.6216.58
Total Current Assets
189.55196.12142.0220.4662.81
Property, Plant & Equipment
0.030.11---
Goodwill
-10.83---
Other Intangible Assets
0.067.88---
Total Assets
189.63214.95142.0220.4662.81
Accrued Expenses
1.841.461.090.940.23
Short-Term Debt
2.35229.6937.2
Current Portion of Leases
0.020.04---
Current Income Taxes Payable
0.090.090.090.10.09
Other Current Liabilities
4.4110.220.420.913
Total Current Liabilities
8.7113.813.5911.6250.52
Long-Term Leases
00.04---
Long-Term Deferred Tax Liabilities
-1.95---
Total Liabilities
8.7115.83.5911.6250.52
Common Stock
0.260.170.040.010.01
Additional Paid-In Capital
405.53405.62210.3271.0271.02
Retained Earnings
-217.58-198.9-63.93-54.47-53.11
Treasury Stock
-3.99-3.99-3.99-3.99-3.99
Comprehensive Income & Other
-3.28-3.77-4.09-3.85-1.65
Total Common Equity
180.93199.12138.378.7312.28
Minority Interest
-0.010.030.060.110
Shareholders' Equity
180.92199.15138.428.8412.29
Total Liabilities & Equity
189.63214.95142.0220.4662.81
Total Debt
2.382.0829.6937.2
Net Cash (Debt)
-2.21174.1583.17-1.76-18.77
Net Cash Growth
-109.38%---
Net Cash Per Share
-0.000.611.76-0.08-0.94
Filing Date Shares Outstanding
856.7551.86145.7222.8722.87
Total Common Shares Outstanding
856.7551.86145.7222.8722.87
Working Capital
180.84182.31138.428.8412.29
Book Value Per Share
0.210.360.950.380.54
Tangible Book Value
180.88180.41138.378.7312.28
Tangible Book Value Per Share
0.210.330.950.380.54
Machinery
0.020.02---
SEC Filings: 10-K · 10-Q